NCI-H2291Homo sapiens (Human)Cancer cell line

Also known as: NCIH2291, H-2291, H2291

🤖 AI SummaryBased on 6 publications

Quick Overview

Human lung cancer cell line with known mutations and drug sensitivity profiles.

Detailed Summary

The NCI-H2291 cell line is a human lung cancer cell line derived from a pleural effusion. It is widely used in cancer research due to its well-characterized genetic profile and drug sensitivity patterns. This cell line has been extensively studied in the context of the Cancer Cell Line Encyclopedia (CCLE) and has been utilized in various studies to understand the molecular mechanisms of cancer and to develop targeted therapies. The cell line exhibits specific mutations that contribute to its oncogenic potential and has been shown to respond to certain chemotherapeutic agents. Its use in preclinical models has provided valuable insights into cancer biology and treatment strategies.

Research Applications

Cancer researchDrug sensitivity profilingMolecular mechanism studies

Key Characteristics

Well-characterized genetic profileDrug sensitivity patternsUsed in CCLE for predictive modeling
Generated on 6/17/2025

Basic Information

Database IDCVCL_1546
SpeciesHomo sapiens (Human)
Tissue SourceLymph node[UBERON:UBERON_0000029]

Donor Information

Age CategoryUnknown
SexMale

Disease Information

DiseaseLung adenocarcinoma
LineageLung
SubtypeLung Adenocarcinoma
OncoTree CodeLUAD

DepMap Information

Source TypeATCC
Source IDACH-000718_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Gly154Val (c.461G>T)Homozygous-Unknown
MutationSimpleKRASp.Gly12Phe (c.34_35GG>TT) (c.34_35delinsTT)Homozygous-Unknown, Unknown, PubMed=12068308

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
12
D13S317
8
D16S539
9,12
D18S51
13
D19S433
13
D21S11
30,30.2
D2S1338
17,20
D3S1358
14,16
D5S818
12
D7S820
9,11
D8S1179
12,14
FGA
23,24
Penta D
12,13
Penta E
7,10
TH01
9,9.3
TPOX
8
vWA
14
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Quantitative proteomics of the Cancer Cell Line Encyclopedia.";

Sellers W.R., Gygi S.P.

Cell 180:387-402.e16(2020).

From clinical specimens to human cancer preclinical models -- a journey the NCI-cell line database-25 years later.

Aldige C.R., Wistuba I.I., Minna J.D.

J. Cell. Biochem. 121:3986-3999(2020).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Mutations of the BRAF gene in human cancer.";

Marshall C.J., Wooster R., Stratton M.R., Futreal P.A.

Nature 417:949-954(2002).

NCI-Navy Medical Oncology Branch cell line data base.";

Carney D.N., Minna J.D., Mulshine J.L.

J. Cell. Biochem. Suppl. 24:32-91(1996).